| PDB code | Main view | Title | | 1bm7 |  | Human transthyretin (prealbumin) complex with flufenamic acid (2-[[3-(trifluoromethyl)phenyl]amino] benzoic acid) |
| 1bmz |  | Human transthyretin (prealbumin) |
| 1bz8 |  | Transthyretin (del val122) |
| 1bzd |  | Tertiary structures of three amyloidogenic transthyretin variants and implications for amyloid fibril formation |
| 1bze |  | Tertiary structures of three amyloidogenic transthyretin variants and implications for amyloid fibril formation |
| 1dvq |  | Crystal structure of human transthyretin |
| 1dvs |  | Crystal structure of human transthyretin in complex with resveratrol |
| 1dvt |  | Crystal structure of human transthyretin in complex with flurbiprofen |
| 1dvu |  | Crystal structure of human transthyretin in complex with dibenzofuran-4,6-dicarboxylic acid |
| 1dvx |  | Crystal structure of human transthyretin in complex with diclofenac |
| 1dvy |  | Crystal structure of transthyretin in complex with n-(m- trifluoromethylphenyl) phenoxazine-4,6-dicarboxylic acid |
| 1dvz |  | Crystal structure of human transthyretin in complex with o- trifluoromethylphenyl anthranilic acid |
| 1e3f |  | Structure of human transthyretin complexed with bromophenols: a new mode of binding |
| 1e4h |  | Structure of human transthyretin complexed with bromophenols: a new mode of binding |
| 1e5a |  | Structure of human transthyretin complexed with bromophenols: a new mode of binding |
| 1eta |  | The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic val 30-->met variant to 1.7 angstroms resolution |
| 1etb |  | The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic val 30-->met variant to 1.7 angstroms resolution |
| 1f41 |  | Crystal structure of human transthyretin at 1.5a resolution |
| 1f86 |  | Transthyretin thr119met protein stabilisation |
| 1fh2 |  | Transthyretin stability as a key factor in amyloidogenesis |
| 1fhn |  | Transthyretin stability as a key factor in amyloidogenesis |
| 1g1o |  | Crystal structure of the highly amyloidogenic transthyretin mutant ttr g53s/e54d/l55s |
| 1gke |  | Rat transthyretin |
| 1gko |  | An engineered transthyretin monomer that is non-amyloidogenic - unless partially denatured |
| 1ict |  | Monoclinic form of human transthyretin complexed with thyroxine (t4) |
| 1ie4 |  | Rat transthyretin complex with thyroxine (t4) |
| 1iii |  | Crystal structure of the transthyretin mutant ttr y114c- data collected at room temperature |
| 1iik |  | Crystal structure of the transthyretin mutant ttr y114c- data collected at cryo temperature |
| 1ijn |  | Crystal structure of the transthyretin mutant ttr c10a/y114c |
| 1kgi |  | Rat transthyretin (also called prealbumin) complex with 3, 3',5,5'-tetraiodothyroacetic acid (t4ac) |
| 1kgj |  | Rat transthyretin (also called prealbumin) complex with 3', 5'-dibromoflavone (emd21388) |
| 1oo2 |  | Crystal structure of transthyretin from sparus aurata |
| 1qab |  | The structure of human retinol binding protein with its carrier protein transthyretin reveals interaction with the carboxy terminus of rbp |
| 1qwh |  | A covalent dimer of transthyretin that affects the amyloid pathway |
| 1rlb |  | Retinol binding protein complexed with transthyretin |
| 1sn0 |  | Crystal structure of sea bream transthyretin in complex with thyroxine at 1.9a resolution |
| 1sn2 |  | Crystal structure of sea bream transthyretin at 1.90a resolution |
| 1sn5 |  | Crystal structure of sea bream transthyretin in complex with triiodothyronine at 1.90a resolution |
| 1sok |  | Crystal structure of the transthyretin mutant a108y/l110e solved in space group p21212 |
| 1soq |  | Crystal structure of the transthyretin mutant a108y/l110e solved in space group c2 |
| 1tfp |  | Transthyretin (formerly known as prealbumin) |
| 1tha |  | Mechanism of molecular recognition. structural aspects of 3, 3'-diiodo-l-thyronine binding to human serum transthyretin |
| 1thc |  | Crystal structure determination at 2.3a of human transthyretin-3',5'-dibromo-2',4,4',6-tetra-hydroxyaurone complex |
| 1tlm |  | Structural aspects of inotropic bipyridine binding: crystal structure determination to 1.9 angstroms of the human serum transthyretin-milrinone complex |
| 1tsh |  | Tertiary structures of three amyloidogenic transthyretin variants and implications for amyloid fibril formation |
| 1tt6 |  | The orthorhombic crystal structure of transthyretin in complex with diethylstilbestrol |
| 1tta |  | The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic val30met variant to 1.7 angstroms resolution |
| 1ttb |  | The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic val30met variant to 1.7 angstroms resolution |
| 1ttc |  | The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic val30met variant to 1.7 angstroms resolution |
| 1ttr |  | Transthyretin-v/122/i cardiomyopathic mutant |
| 1tyr |  | Transthyretin complex with retinoic acid |
| 1tz8 |  | The monoclinic crystal struture of transthyretin in complex with diethylstilbestrol |
| 1u21 |  | Transthyretin with tethered inhibitor on one monomer. |
| 1x7s |  | The x-ray crystallographic structure of the amyloidogenic variant ttr tyr78phe |
| 1x7t |  | Structure of ttr r104h: a non-amyloidogenic variant with protective clinical effects |
| 1y1d |  | Crystal structure of transthyretin in complex with iododiflunisal |
| 1z7j |  | Human transthyretin (also called prealbumin) complex with 3, 3',5,5'-tetraiodothyroacetic acid (t4ac) |
| 1zcr |  | Crystal structure of human transthyretin with bound iodide |
| 1zd6 |  | Crystal structure of human transthyretin with bound chloride |
| 2b14 |  | The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant transthyretin leu 55 pro |
| 2b15 |  | The crystal structure of 2,4-dinitrophenol in complex with human transthyretin |
| 2b16 |  | The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant transthyretin tyr78phe |
| 2b77 |  | Human transthyretin (ttr) complexed with diflunisal analogues- ttr.2',4'-dichloro-4-hydroxy-1,1'-biphenyl-3- carboxylic acid |
| 2b9a |  | Human transthyretin (ttr) complexed with diflunisal analogues- ttr.3',5'-difluorobiphenyl-4-carboxylic acid |
| 2f7i |  | Human transthyretin (ttr) complexed with diflunisal analogues- ttr. 2',6'-difluorobiphenyl-4-carboxylic acid |
| 2f8i |  | Human transthyretin (ttr) complexed with benzoxazole |
| 2fbr |  | Human transthyretin (ttr) complexed with bivalant amyloid inhibitor (4 carbon linker) |
| 2flm |  | Human transthyretin (ttr) complexed with bivalant amyloid inhibitor (6 carbon linker) |
| 2g2n |  | Crystal structure of e.coli transthyretin-related protein with bound zn |
| 2g2p |  | Crystal structure of e.coli transthyretin-related protein with bound zn and br |
| 2g3x |  | Crystal structure of transthyretin mutant i84s at acidic ph |
| 2g3z |  | Crystal structure of transthyretin mutant i84a at low ph |
| 2g4e |  | Crystal structure of transthyretin mutant i84a at neutral ph |
| 2g4g |  | Crystal structure of human transthyretin at ph 4.6 |
| 2g5u |  | Human transthyretin (ttr) complexed with hydroxylated polychlorinated biphenyl-4,4'-dihydroxy-3,3',5,5'- tetrachlorobiphenyl |
| 2g9k |  | Human transthyretin (ttr) complexed with hydroxylated polychlorinated biphenyl-4-hydroxy-2',3,3',4',5- pentachlorobiphenyl |
| 2gab |  | Human transthyretin (ttr) complexed with hydroxylated polychlorinated biphenyl-4-hydroxy-3,3',5,4'- tetrachlorobiphenyl |
| 2gpz |  | Transthyretin-like protein from salmonella dublin |
| 2h0e |  | Crystal structure of pucm in the absence of substrate |
| 2h0f |  | Crystal structure of pucm in the presence of 8-azaxanthine |
| 2h0j |  | Crystal structure of pucm in the presence of 5,6- diaminouracil |
| 2h1x |  | Crystal structure of 5-hydroxyisourate hydrolase (formerly known as trp, transthyretin related protein) |
| 2h4e |  | Crystal structure of cys10 sulfonated transthyretin |
| 2h6u |  | Crystal structure of 5-hydroxyisourate hydrolase (formerly known as trp, transthyretin related protein) |
| 2igl |  | Crystal structure of e. coli yedx, a transthyretin related protein |
| 2noy |  | Crystal structure of transthyretin mutant i84s at ph 7.5 |
| 2pab |  | Structure of prealbumin, secondary, tertiary and quaternary interactions determined by fourier refinement at 1.8 angstroms |
| 2qel |  | Crystal structure of the highly amyloidogenic transthyretin mutant ttr g53s/e54d/l55s- heated protein |
| 2qgb |  | Human transthyretin (ttr) in apo-form |
| 2qgc |  | Human transthyretin (ttr) complexed with 2-(3,5-dimethyl-4- hydroxyphenyl)benzoxazole |
| 2qgd |  | Human transthyretin (ttr) complexed with 2-(3,5-dibromo-4- hydroxyphenyl)benzoxazole |
| 2qge |  | Human transthyretin (ttr) complexed with 2-(3,5- dimethylphenyl)benzoxazole |
| 2qpf |  | Crystal structure of mouse transthyretin |
| 2rox |  | Transthyretin (also called prealbumin) complex with thyroxine (t4) |
| 2roy |  | Transthyretin (also called prealbumin) complex with 3',5'- dinitro-n-acetyl-l-thyronine |
| 2trh |  | Tertiary structures of three amyloidogenic transthyretin variants and implications for amyloid fibril formation |
| 2try |  | Tertiary structures of three amyloidogenic transthyretin variants and implications for amyloid fibril formation |
| 3b56 |  | Crystal structure of transthyretin in complex with 3,5- diiodosalicylic acid |
| 3bsz |  | Crystal structure of the transthyretin-retinol binding protein-fab complex |
| 3bt0 |  | Crystal structure of transthyretin variant v20s |
| 3cbr |  | Crystal structure of human transthyretin (ttr) at ph3.5 |
| 3cfm |  | Crystal structure of the apo form of human wild-type transthyretin |
| 3cfn |  | Crystal structure of human transthyretin in complex with 1- anilino-8-naphthalene sulfonate |
| 3cfq |  | Crystal structure of human wild-type transthyretin in complex with diclofenac |
| 3cft |  | Crystal structure of human transthyretin in complex with 1- amino-5-naphthalene sulfonate |
| 3cn0 |  | Human transthyretin (ttr) in complex with 3,5-dimethyl-4- hydroxystilbene |
| 3cn1 |  | Human transthyretin (ttr) in complex with 3,5-dibromo-4- hydroxystilbene |
| 3cn2 |  | Human transthyretin (ttr) in complex with 3,5-dibromo-4- hydroxybiphenyl |
| 3cn3 |  | Human transthyretin (ttr) in complex with 1,3-dibromo-2- hydroxy-5-phenoxybenzene |
| 3cn4 |  | Human transthyretin (ttr) in complex with n-(3,5-dibromo-4- hydroxyphenyl)benzamide |
| 3cxf |  | Crystal structure of transthyretin variant y114h |
| 3cyk |  | Crystal structure of the f87m/l110m mutant of human transthyretin at ph 4.6. |
| 3d2t |  | Human transthyretin (ttr) complexed with diflunisal |
| 3d7p |  | Crystal structure of human transthyretin (ttr) at ph 4.0 |
| 3dgd |  | Crystal structure of the f87m/l110m mutant of human transthyretin at ph 4.6 |
| 3did |  | Crystal structure of the f87m/l110m mutant of human transthyretin at ph 4.6 soaked |
| 3djr |  | Crystal structure of transthyretin variant l58h at neutral ph |
| 3djs |  | Crystal structure of transthyretin variant l58h at acidic ph |
| 3djt |  | Crystal structure of transthyretin variant v30m at acidic ph |
| 3djz |  | Crystal structure of transthyretin variant l55p at neutral ph |
| 3dk0 |  | Crystal structure of transthyretin variant l55p at acidic ph |
| 3dk2 |  | Crystal structure of transthyretin variant y114h at acidic ph |
| 3do4 |  | Crystal structure of transthyretin variant t60a at acidic ph |
| 3esn |  | Human transthyretin (ttr) complexed with n-(3,5-dibromo-4- hydroxyphenyl)-2,6-dimethylbenzamide |
| 3eso |  | Human transthyretin (ttr) complexed with n-(3,5-dibromo-4- hydroxyphenyl)-2,5-dichlorobenzamide |
| 3esp |  | Human transthyretin (ttr) complexed with n-(3,5-dibromo-4- hydroxyphenyl)-3,5-dimethyl-4-hydroxybenzamide |
| 3fc8 |  | Crystal structure of transthyretin in complex with iododiflunisal-betaalaome |
| 3fcb |  | Crystal structure of transthyretin in complex with iododiflunisal-betaalaoh |
| 3glz |  | Human transthyretin (ttr) complexed with(e)-3-(2- (trifluoromethyl)benzylideneaminooxy)propanoic acid (inhibitor 11) |
| 3gs0 |  | Human transthyretin (ttr) complexed with (s)-3-(9h-fluoren- 9-ylideneaminooxy)-2-methylpropanoic acid (inhibitor 16) |
| 3gs4 |  | Human transthyretin (ttr) complexed with 3-(9h-fluoren-9- ylideneaminooxy)propanoic acid (inhibitor 15) |
| 3gs7 |  | Human transthyretin (ttr) complexed with (e)-3-(2- methoxybenzylideneaminooxy)propanoic acid (inhibitor 13) |
| 3i9p |  | Crystal structure of human transthyretin - wild type |
| 5ttr |  | Leu 55 pro transthyretin crystal structure |